Cormorant Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-200,000
| Closed | -$3.03M | – | 68 |
|
|
2019
Q1 | $3.03M | Sell |
200,000
-45,370
| -18% | -$687K | 0.2% | 56 |
|
|
2018
Q4 | $4.21M | Sell |
245,370
-4,630
| -2% | -$79.5K | 0.34% | 49 |
|
|
2018
Q3 | $3.69M | Sell |
250,000
-36,668
| -13% | -$540K | 0.24% | 49 |
|
|
2018
Q2 | $6.84M | Hold |
286,668
| – | – | 0.51% | 43 |
|
|
2018
Q1 | $7.32M | Sell |
286,668
-13,332
| -4% | -$341K | 0.55% | 30 |
|
|
2017
Q4 | $5.54M | Hold |
300,000
| – | – | 0.58% | 33 |
|
|
2017
Q3 | $3.15M | Hold |
300,000
| – | – | 0.56% | 40 |
|
|
2017
Q2 | $3.75M | Hold |
300,000
| – | – | 0.62% | 43 |
|
|
2017
Q1 | $3.02M | Sell |
300,000
-155,515
| -34% | -$1.56M | 0.44% | 50 |
|
|
2016
Q4 | $7.09M | Hold |
455,515
| – | – | 0.96% | 32 |
|
|
2016
Q3 | $8.77M | Hold |
455,515
| – | – | 0.97% | 33 |
|
|
2016
Q2 | $5.4M | Buy |
455,515
+5,515
| +1% | +$65.4K | 0.77% | 42 |
|
|
2016
Q1 | $8.17M | Hold |
450,000
| – | – | 1.23% | 30 |
|
|
2015
Q4 | $12.4M | Hold |
450,000
| – | – | 1.48% | 26 |
|
|
2015
Q3 | $9.95M | Hold |
450,000
| – | – | 1.59% | 23 |
|
|
2015
Q2 | $8.03M | Buy |
+450,000
| New | +$8.03M | 1.07% | 31 |
|